ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Skin Cancer of the Head and Neck · Treatment in China

Can I continue immunotherapy for melanoma or advanced skin cancer while in China?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Skin Cancer of the Head and Neck Answer length: short, citable
Quick answer

Often yes, but it must be arranged in advance. PD-1 inhibitors, CTLA-4 inhibitors and BRAF/MEK targeted agents are used in Chinese tertiary centres, yet the specific brand, dose, cycle interval, stock and price may differ from your home regimen. Continuing an established regimen without a verified plan risks an unplanned treatment gap.

In detail

Bring the exact drug name, dose, cycle dates, last infusion date, recent imaging and any immune-related adverse-event history. Ask for a written continuation plan and for the cycle schedule in English; also confirm how immune-related side effects would be managed while you are abroad.

What this means in practice: this answer is part of the “Treatment in China” section of the Skin Cancer of the Head and Neck topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about skin cancer of the head and neck

See all 14 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionIs Mohs surgery appropriate for facial skin cancer? Next question →What does head and neck skin cancer treatment cost in China?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.